<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36379713</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Motor cortex functional connectivity is associated with underlying neurochemistry in ALS.</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>200</EndPage><MedlinePgn>193-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2022-329993</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To identify structural and neurochemical properties that underlie functional connectivity impairments of the primary motor cortex (PMC) and how these relate to clinical findings in amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS">52 patients with ALS and 52 healthy controls, matched for age and sex, were enrolled from 5 centres across Canada for the Canadian ALS Neuroimaging Consortium study. Resting-state functional MRI, diffusion tensor imaging and magnetic resonance spectroscopy data were acquired. Functional connectivity maps, diffusion metrics and neurometabolite ratios were obtained from the analyses of the acquired multimodal data. A clinical assessment of foot tapping (frequency) was performed to examine upper motor neuron function in all participants.</AbstractText><AbstractText Label="RESULTS">Compared with healthy controls, the primary motor cortex in ALS showed reduced functional connectivity with sensory (T=5.21), frontal (T=3.70), temporal (T=3.80), putaminal (T=4.03) and adjacent motor (T=4.60) regions. In the primary motor cortex, N-acetyl aspartate (NAA, a neuronal marker) ratios and diffusion metrics (mean, axial and radial diffusivity, fractional anisotropy (FA)) were altered. Within the ALS cohort, foot tapping frequency correlated with NAA (r=0.347) and white matter FA (r=0.537). NAA levels showed associations with disturbed functional connectivity of the motor cortex.</AbstractText><AbstractText Label="CONCLUSION"><i>In vivo</i> neurochemistry may represent an effective imaging marker of impaired motor cortex functional connectivity in ALS.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Avyarthana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3760-4129</Identifier><AffiliationInfo><Affiliation>Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luk</LastName><ForeName>Collin C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-5995-4314</Identifier><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishaque</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine &amp; Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ta</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4975-2970</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine &amp; Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>Ojas</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Faculty of Medicine &amp; Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krebs</LastName><ForeName>Dennell</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medicine &amp; Dentistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seres</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanstock</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaulieu</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korngut</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frayne</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Seaman Family Magnetic Resonance Research Centre, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9647-6569</Identifier><AffiliationInfo><Affiliation>Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genge</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Montreal Neurological Institute and Hospital, McGill University, Montreal, Qu&#xe9;bec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briemberg</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada kalra@ualberta.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian ALS Neuroimaging Consortium (CALSNIC)</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>123534</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009448" MajorTopicYN="Y">Neurochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FUNCTIONAL IMAGING</Keyword><Keyword MajorTopicYN="N">MOTOR NEURON DISEASE</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">MRS</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36379713</ArticleId><ArticleId IdType="pmc">PMC9985743</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2022-329993</ArticleId><ArticleId IdType="pii">jnnp-2022-329993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014;10:661&#x2013;70. 10.1038/nrneurol.2014.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi B, Kollewe K, Cole DM, et al. . Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring. Hum Brain Mapp 2015;36:2878&#x2013;89. 10.1002/hbm.22814</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22814</ArticleId><ArticleId IdType="pmc">PMC6869134</ArticleId><ArticleId IdType="pubmed">25913637</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi M, de Marco G, Couillandre A, et al. . Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changes. Eur J Neurol 2020;27:1&#x2013;8. 10.1111/ene.14042</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14042</ArticleId><ArticleId IdType="pubmed">31310452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Xu R, Dowd E, et al. . Alterations in regional functional coherence within the sensory-motor network in amyotrophic lateral sclerosis. Neurosci Lett 2014;558:192&#x2013;6. 10.1016/j.neulet.2013.11.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.11.022</ArticleId><ArticleId IdType="pubmed">24275213</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno APA, Pinaya WHL, Rebello K, et al. . Regional dynamics of the resting brain in amyotrophic lateral sclerosis using fractional amplitude of low-frequency fluctuations and regional homogeneity analyses. Brain Connect 2019;9:356&#x2013;64. 10.1089/brain.2019.0663</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2019.0663</ArticleId><ArticleId IdType="pubmed">30793923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenji S, Jha S, Lee D, et al. . Investigating default mode and sensorimotor network connectivity in amyotrophic lateral sclerosis. PLoS One 2016;11:e0157443. 10.1371/journal.pone.0157443</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0157443</ArticleId><ArticleId IdType="pmc">PMC4913931</ArticleId><ArticleId IdType="pubmed">27322194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Chen G, He M, et al. . Altered white matter microarchitecture in amyotrophic lateral sclerosis: a voxel-based meta-analysis of diffusion tensor imaging. Neuroimage Clin 2018;19:122&#x2013;9. 10.1016/j.nicl.2018.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.04.005</ArticleId><ArticleId IdType="pmc">PMC6051469</ArticleId><ArticleId IdType="pubmed">30035009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Ma L. Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: a voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler 2010;11:549&#x2013;54. 10.3109/17482968.2010.516265</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.516265</ArticleId><ArticleId IdType="pubmed">20929296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S. Magnetic resonance spectroscopy in ALS. Front Neurol 2019;10. 10.3389/fneur.2019.00482</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00482</ArticleId><ArticleId IdType="pmc">PMC6524558</ArticleId><ArticleId IdType="pubmed">31133975</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Filippini N, Knight S, et al. . Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain 2011;134:3470&#x2013;9. 10.1093/brain/awr279</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr279</ArticleId><ArticleId IdType="pubmed">22075069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratai E-M, Alshikho MJ, Z&#xfc;rcher NR, et al. . Integrated imaging of [1 1C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis. Neuroimage Clin 2018;20:357&#x2013;64. 10.1016/j.nicl.2018.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.08.007</ArticleId><ArticleId IdType="pmc">PMC6092554</ArticleId><ArticleId IdType="pubmed">30112276</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Carlos RC, Dwamena BA, et al. . Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann Clin Transl Neurol 2014;1:107&#x2013;14. 10.1002/acn3.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.30</ArticleId><ArticleId IdType="pmc">PMC4212480</ArticleId><ArticleId IdType="pubmed">25356389</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Proudfoot M, Talbot K, et al. . The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. Neuroimage Clin 2018;17:953&#x2013;61. 10.1016/j.nicl.2017.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.12.025</ArticleId><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Yuan Y, Tang X, et al. . Structural and functional underpinnings of precentral abnormalities in amyotrophic lateral sclerosis. Eur J Neurol 2021;28:1&#x2013;9. 10.1111/ene.14717</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14717</ArticleId><ArticleId IdType="pubmed">33404153</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjay Kalra A, Khan M, Barlow L, et al. . The Canadian ALS Neuroimaging Consortium (CALSNIC)-a multicentre platform for standardized imaging and clinical studies in ALS. medRxiv 2020.. 10.1101/2020.07.10.20142679</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.10.20142679</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000;1:293&#x2013;9. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava O, Hanstock C, Chenji S, et al. . Cerebral degeneration in amyotrophic lateral sclerosis: a prospective multicenter magnetic resonance spectroscopy study. Neurol Clin Pract 2019;9:400&#x2013;7. 10.1212/CPJ.0000000000000674</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000674</ArticleId><ArticleId IdType="pmc">PMC6814429</ArticleId><ArticleId IdType="pubmed">31750025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta D, Ishaque A, Srivastava O, et al. . Progressive neurochemical abnormalities in cognitive and motor subgroups of amyotrophic lateral sclerosis: a prospective multicenter study. Neurology 2021;97:e803&#x2013;13. 10.1212/WNL.0000000000012367</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012367</ArticleId><ArticleId IdType="pmc">PMC8397589</ArticleId><ArticleId IdType="pubmed">34426551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishaque A, Mah D, Seres P, et al. . Corticospinal tract degeneration in ALS unmasked in T1-weighted images using texture analysis. Hum Brain Mapp 2019;40:1174&#x2013;83. 10.1002/hbm.24437</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24437</ArticleId><ArticleId IdType="pmc">PMC6865626</ArticleId><ArticleId IdType="pubmed">30367724</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner RL, Sepulcre J, Talukdar T, et al. . Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 2009;29:1860&#x2013;73. 10.1523/JNEUROSCI.5062-08.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5062-08.2009</ArticleId><ArticleId IdType="pmc">PMC2750039</ArticleId><ArticleId IdType="pubmed">19211893</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins DL, Peters TM, Dai W. Model-based segmentation of individual brain structures from MRI data 1992;1808:10&#x2013;23.</Citation></Reference><Reference><Citation>Mohammadi B, Kollewe K, Samii A, et al. . Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol 2009;217:147&#x2013;53. 10.1016/j.expneurol.2009.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.01.025</ArticleId><ArticleId IdType="pubmed">19416664</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Canu E, Valsasina P, et al. . Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging 2013;34:419&#x2013;27. 10.1016/j.neurobiolaging.2012.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.04.015</ArticleId><ArticleId IdType="pubmed">22608240</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Zhang Y, Wang Y, et al. . Disrupted effective connectivity of the sensorimotor network in amyotrophic lateral sclerosis. J Neurol 2016;263:508&#x2013;16. 10.1007/s00415-015-8013-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-8013-z</ArticleId><ArticleId IdType="pubmed">26743627</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, van den Heuvel MP, Veldink JH, et al. . Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS One 2010;5:e13664. 10.1371/journal.pone.0013664</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013664</ArticleId><ArticleId IdType="pmc">PMC2965124</ArticleId><ArticleId IdType="pubmed">21060689</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Gong H, Li F, et al. . Altered motor network functional connectivity in amyotrophic lateral sclerosis: a resting-state functional magnetic resonance imaging study. Neuroreport 2013;24:657&#x2013;62. 10.1097/WNR.0b013e328363148c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0b013e328363148c</ArticleId><ArticleId IdType="pubmed">23839257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ji B, Hu J, et al. . Aberrant interhemispheric homotopic functional and structural connectivity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2017;88:374&#x2013;80. 10.1136/jnnp-2016-314567</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314567</ArticleId><ArticleId IdType="pubmed">27913627</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt R, Verstraete E, de Reus MA, et al. . Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:4386&#x2013;95. 10.1002/hbm.22481</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22481</ArticleId><ArticleId IdType="pmc">PMC4207190</ArticleId><ArticleId IdType="pubmed">24604691</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu T, Zhang Y, Tang X, et al. . Precentral degeneration and cerebellar compensation in amyotrophic lateral sclerosis: a multimodal MRI analysis. Hum Brain Mapp 2019;40:3464&#x2013;74. 10.1002/hbm.24609</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24609</ArticleId><ArticleId IdType="pmc">PMC6865414</ArticleId><ArticleId IdType="pubmed">31020731</ArticleId></ArticleIdList></Reference><Reference><Citation>Skudlarski P, Jagannathan K, Anderson K, et al. . Brain connectivity is not only lower but different in schizophrenia: a combined anatomical and functional approach. Biol Psychiatry 2010;68:61&#x2013;9. 10.1016/j.biopsych.2010.03.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2010.03.035</ArticleId><ArticleId IdType="pmc">PMC2900394</ArticleId><ArticleId IdType="pubmed">20497901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Liao W, Chen H, et al. . Altered functional-structural coupling of large-scale brain networks in idiopathic generalized epilepsy. Brain 2011;134:2912&#x2013;28. 10.1093/brain/awr223</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr223</ArticleId><ArticleId IdType="pubmed">21975588</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, Zou Y, Zheng W, et al. . Structural alterations of the brain preceded functional alterations in major depressive disorder patients: evidence from multimodal connectivity. J Affect Disord 2019;253:107&#x2013;17. 10.1016/j.jad.2019.04.064</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2019.04.064</ArticleId><ArticleId IdType="pubmed">31035211</ArticleId></ArticleIdList></Reference><Reference><Citation>Rektor I, Sv&#xe1;tkov&#xe1; A, Vojt&#xed;&#x161;ek L, et al. . White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy. PLoS One 2018;13:e0187939. 10.1371/journal.pone.0187939</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187939</ArticleId><ArticleId IdType="pmc">PMC5755732</ArticleId><ArticleId IdType="pubmed">29304183</ArticleId></ArticleIdList></Reference><Reference><Citation>Koubiyr I, Besson P, Deloire M, et al. . Dynamic modular-level alterations of structural-functional coupling in clinically isolated syndrome. Brain 2019;142:3428&#x2013;39. 10.1093/brain/awz270</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz270</ArticleId><ArticleId IdType="pubmed">31504228</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Testa N, Jordan R. Functional connectivity between the resting-state olfactory network and the hippocampus in Alzheimer&#x2019;s disease. Brain Sci 2019;9:338. 10.3390/brainsci9120338</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9120338</ArticleId><ArticleId IdType="pmc">PMC6955985</ArticleId><ArticleId IdType="pubmed">31775369</ArticleId></ArticleIdList></Reference><Reference><Citation>Low A, Foo H, Yong TT, et al. . Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 2019;90:681&#x2013;7. 10.1136/jnnp-2018-319592</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319592</ArticleId><ArticleId IdType="pubmed">30683708</ArticleId></ArticleIdList></Reference><Reference><Citation>George A, Kuzniecky R, Rusinek H, et al. . Standardized brain MRI acquisition protocols improve statistical power in multicenter quantitative morphometry studies. J Neuroimaging 2020;30:126&#x2013;33. 10.1111/jon.12673</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12673</ArticleId><ArticleId IdType="pmc">PMC7391934</ArticleId><ArticleId IdType="pubmed">31664774</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162&#x2013;72. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. . Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:153&#x2013;74. 10.1080/21678421.2016.1267768</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Rentzos M, et al. . Clinical and radiological markers of extra-motor deficits in amyotrophic lateral sclerosis. Front Neurol 2018;9:1005. 10.3389/fneur.2018.01005</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01005</ArticleId><ArticleId IdType="pmc">PMC6262087</ArticleId><ArticleId IdType="pubmed">30524366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330:585&#x2013;91. 10.1056/NEJM199403033300901</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, Cashman NR, Genge A, et al. . Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757&#x2013;61. 10.1097/00001756-199806010-00016</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199806010-00016</ArticleId><ArticleId IdType="pubmed">9665596</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>